Prognostic factors affecting survival in third-line treatment of advanced non-small cell lung cancer: Retrospective cohort study
F Aslan, U Demirci, D Kızılgöz, F Yıldız… - Journal of Surgery and … - dergipark.org.tr
Aim: In patients who have reached third-line treatment, survival times are short and
response to treatment is poor. However, in some patients, survival times and treatment …
response to treatment is poor. However, in some patients, survival times and treatment …
[HTML][HTML] Prognostic factors affecting survival in third-line treatment of advanced non-small cell lung cancer: Retrospective cohort study
F Aslan, U Demirci, D Kızılgöz, F Yıldız… - Journal of Surgery and …, 2020 - jsurgmed.com
Aim: In patients who have reached third-line treatment, survival times are short and
response to treatment is poor. However, in some patients, survival times and treatment …
response to treatment is poor. However, in some patients, survival times and treatment …
Prognostic factors affecting survival in third-line treatment of advanced non-small cell lung cancer: Retrospective cohort study.
F Aslan, U Demirci, D Kızılgöz, F Yıldız… - Journal of Surgery …, 2020 - search.ebscohost.com
Aim: In patients who have reached third-line treatment, survival times are short and
response to treatment is poor. However, in some patients, survival times and treatment …
response to treatment is poor. However, in some patients, survival times and treatment …
[HTML][HTML] Prognostic factors affecting survival in third-line treatment of advanced non-small cell lung cancer: Retrospective cohort study
F Aslan, U Demirci, D Kızılgöz, F Yıldız… - Journal of Surgery and … - dergipark.org.tr
Aim: In patients who have reached third-line treatment, survival times are short and
response to treatment is poor. However, in some patients, survival times and treatment …
response to treatment is poor. However, in some patients, survival times and treatment …
[PDF][PDF] Prognostic factors affecting survival in third-line treatment of advanced non-small cell lung cancer: Retrospective cohort study
F Aslan, U Demirci, D Kızılgöz, F Yıldız, PA Kabalak… - Age, 2020 - scholar.archive.org
Aim: In patients who have reached third-line treatment, survival times are short and
response to treatment is poor. However, in some patients, survival times and treatment …
response to treatment is poor. However, in some patients, survival times and treatment …